Galatea Bio
Precision Medicine & Genomics
Galatea Bio is a genomics company developing AI-powered tools to analyze genetic data and identify disease risk factors for precision medicine.
About Galatea Bio
Galatea Bio uses AI and large-scale genomic data to identify genetic risk factors and develop precision medicine solutions for complex diseases.
Leadership Team
Key executives and founders sourced from public LinkedIn profiles.
Products & Solutions
Galatea Bio Platform
FlagshipplatformPrecision medicine platform for genomics and therapeutic development
Galatea Bio appears to operate in the precision medicine and genomics space, likely providing computational or analytical tools for therapeutic development and genomic analysis. Based on the limited information available, the company focuses on leveraging genomic data for precision medicine applications.
Hiring Activity
Product & Market
Product Stage
unknownPrimary Market
unknownCompany Details
- Founded
- 2020
- Headquarters
- Reykjavik, Iceland
- Employees
- 50
- Stage
- series b
- Profile last updated
- June 22, 2026
Category
Precision Medicine & GenomicsOfficial Sources
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingData Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as employee counts and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.